de Ferranti Sarah, Mozaffarian Dariush
Department of Cardiology, Children's Hospital Boston, Boston, MA 02115, USA.
Clin Chem. 2008 Jun;54(6):945-55. doi: 10.1373/clinchem.2007.100156. Epub 2008 Apr 24.
As the prevalence of adiposity soars in both developed and developing nations, appreciation of the close links between obesity and disease increases. The strong relationships between excess adipose tissue and poor health outcomes, including cardiovascular disease, diabetes, and cancer, mandate elucidation of the complex cellular, hormonal, and molecular pathophysiology whereby adiposity initiates and maintains adverse health effects.
In this report we review adipocyte metabolism and function in the context of energy imbalance and postprandial nutrient excess, including adipocyte hypertrophy and hyperplasia, adipocyte dysfunction, and other systemic consequences. We also discuss implications for laboratory evaluation and clinical care, including the role of lifestyle modifications. Chronic energy imbalance produces adipocyte hypertrophy and hyperplasia, endoplasmic reticulum stress, and mitochondrial dysfunction. These processes lead to increased intracellular and systemic release of adipokines, free fatty acids, and inflammatory mediators that cause adipocyte dysfunction and induce adverse effects in the liver, pancreatic beta-cells, and skeletal muscle as well as the heart and vascular beds. Several specialized laboratory tests can quantify these processes and predict clinical risk, but translation to the clinical setting is premature. Current and future pharmacologic interventions may target these pathways; modest changes in diet, physical activity, weight, and smoking are likely to have the greatest impact.
Adipocyte endoplasmic reticulum and mitochondrial stress, and associated changes in circulating adipokines, free fatty acids, and inflammatory mediators, are central to adverse health effects of adiposity. Future investigation should focus on these pathways and on reversing the adverse lifestyle behaviors that are the fundamental causes of adiposity.
随着肥胖症在发达国家和发展中国家的患病率飙升,人们对肥胖与疾病之间紧密联系的认识也在增加。过多的脂肪组织与包括心血管疾病、糖尿病和癌症在内的不良健康结果之间的密切关系,要求阐明肥胖引发并维持不良健康影响的复杂细胞、激素和分子病理生理学机制。
在本报告中,我们在能量失衡和餐后营养过剩的背景下回顾脂肪细胞的代谢和功能,包括脂肪细胞肥大和增生、脂肪细胞功能障碍以及其他全身后果。我们还讨论了对实验室评估和临床护理的影响,包括生活方式改变的作用。慢性能量失衡会导致脂肪细胞肥大和增生、内质网应激和线粒体功能障碍。这些过程会导致脂肪细胞因子、游离脂肪酸和炎症介质在细胞内和全身的释放增加,从而导致脂肪细胞功能障碍,并在肝脏、胰腺β细胞、骨骼肌以及心脏和血管床中引发不良反应。几种专门的实验室检测可以量化这些过程并预测临床风险,但将其转化到临床应用还为时过早。当前和未来的药物干预可能针对这些途径;饮食、体育活动、体重和吸烟方面的适度改变可能会产生最大影响。
脂肪细胞内质网和线粒体应激,以及循环中的脂肪细胞因子、游离脂肪酸和炎症介质的相关变化,是肥胖对健康产生不良影响的核心。未来的研究应聚焦于这些途径,以及扭转作为肥胖根本原因的不良生活方式行为。